IC43 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pneumonia, Ventilator-Associated
Conditions
Pneumonia, Ventilator-Associated
Trial Timeline
Dec 1, 2008 → Feb 1, 2010
NCT ID
NCT00876252About IC43 + Placebo
IC43 + Placebo is a phase 2 stage product being developed by Valneva SE for Pneumonia, Ventilator-Associated. The current trial status is completed. This product is registered under clinical trial identifier NCT00876252. Target conditions include Pneumonia, Ventilator-Associated.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01563263 | Phase 2/3 | Completed |
| NCT00876252 | Phase 2 | Completed |
| NCT00778388 | Phase 1 | Completed |
Competing Products
20 competing products in Pneumonia, Ventilator-Associated